NCT06625515
First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients with Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers No drug interventions treatment 1 not_yet_recruiting NCT02947061
S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer treatment 2 unknown_status NCT05406661
Registry of Local Recurrences After Breast-conserving Surgery No drug interventions Not Available Not Available not_yet_recruiting NCT02248571
Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab other 4 completed NCT02844335
Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer No drug interventions treatment 1 / 2 completed NCT05464082
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC No drug interventions treatment 2 recruiting NCT05301010
Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients treatment 3 completed NCT02915445
EpCAM CAR-T for Treatment of Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT06458413
Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer treatment 2 recruiting NCT04330339
Prolonged Nightly Fasting in Breast Cancer Survivors No drug interventions supportive_care Not Available completed NCT05301530
Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients. treatment 1 completed NCT03820830
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer treatment 3 recruiting NCT01552655
Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT No drug interventions diagnostic Not Available completed NCT05730608
18F-FDG PET/CT Imaging for Breast Cancer No drug interventions diagnostic Not Available recruiting NCT05592938
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) No drug interventions treatment Not Available recruiting NCT06369285
A Study of Alisertib in Combination with Endocrine Therapy in Patients with HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer treatment 2 recruiting NCT04360941
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer other 1 recruiting NCT02390427
Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combination With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Cancer treatment 1 completed NCT05274451
A Study to Investigate LYL797 in Adults with Solid Tumors No drug interventions treatment 1 recruiting NCT05891197
A Biomarker Screening Protocol for Participants With Solid Tumors No drug interventions Not Available Not Available recruiting NCT01249443
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection treatment 1 terminated NCT01037790
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer treatment 2 completed NCT02046421
Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT00992602
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer treatment 2 completed NCT00132002
Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer treatment 2 terminated NCT01147484
A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer treatment 2 completed NCT01672684
Phase I: At-Home Support for Rural Women Using Group Video Calling No drug interventions supportive_care 1 completed NCT03602079
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene No drug interventions treatment 1 / 2 completed NCT01730833
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer treatment 2 active_not_recruiting NCT01819233
Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy No drug interventions supportive_care Not Available completed NCT01276054
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients. supportive_care 2 terminated NCT00024154
Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT02060253
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer treatment 1 completed NCT01233505
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors treatment 1 terminated NCT01245205
Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer treatment 1 completed NCT00098605
Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases treatment 2 completed NCT01009983
Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer treatment 2 terminated NCT01292083
Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery treatment Not Available withdrawn NCT01288261
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer treatment 1 completed NCT06202261
A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer treatment 1 / 2 recruiting NCT01394211
Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer treatment 2 terminated NCT00004888
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer treatment 2 completed NCT00095888
3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer treatment 2 terminated NCT00068588
GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT00559507
Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery treatment 2 completed NCT00030615
Decitabine in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT00416715
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer supportive_care 2 completed NCT01013337
Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain No drug interventions supportive_care Not Available completed NCT00791037
Vaccine Therapy in Treating Patients With Stage IV Breast Cancer treatment 1 / 2 completed NCT01729832
Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer No drug interventions supportive_care Not Available withdrawn NCT04382352
B002 in Patients With HER2-positive Breast Cancer No drug interventions treatment 1 completed NCT02273752
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer treatment 2 terminated NCT00331552
Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer treatment 1 / 2 completed NCT01104259
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer treatment 1 completed NCT02015559
Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus No drug interventions supportive_care 2 completed NCT01339442
BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer treatment 1 completed NCT00071942
Vaccine Therapy in Treating Patients With Metastatic Breast Cancer No drug interventions treatment 1 terminated NCT00348699
AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery No drug interventions treatment 1 completed NCT00217399
Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer treatment 1 / 2 completed NCT00003536
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer treatment 2 withdrawn NCT01824836
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) supportive_care Not Available active_not_recruiting NCT06202118
A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients. No drug interventions treatment Not Available recruiting NCT00057941
Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer treatment 2 completed NCT00005817
Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer treatment 2 completed NCT01421017
Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases treatment 1 / 2 completed NCT00096434
Sorafenib in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT00028496
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer treatment 1 completed NCT00159458
Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer treatment 2 terminated NCT01042535
Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer treatment 1 / 2 completed NCT00053339
Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer treatment 3 withdrawn NCT01881230
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) treatment 2 / 3 completed NCT01084057
Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer treatment 1 completed NCT00079326
Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer treatment 2 terminated NCT02843126
Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast Cancer treatment 1 / 2 completed NCT01987726
Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors No drug interventions Not Available Not Available completed NCT01158274
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors treatment 1 completed NCT02226276
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer diagnostic Not Available active_not_recruiting NCT00017394
Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer treatment 2 completed NCT00089362
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors treatment 1 completed NCT01385280
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer treatment Not Available completed NCT02041429
Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca treatment 1 / 2 completed NCT01730729
Cabergoline in Metastatic Breast Cancer treatment 0 completed NCT01764789
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer No drug interventions supportive_care Not Available completed NCT03890744
ModraDoc006/r in Patients With Breast Cancer treatment 2 completed NCT00003440
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic treatment 3 completed NCT01051401
Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer treatment 1 terminated NCT01153672
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy treatment Not Available completed NCT01986569
Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer No drug interventions diagnostic 3 completed NCT00082810
Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer treatment 2 completed NCT01493310
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer treatment 1 completed NCT02038010
BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx treatment 1 completed NCT00031681
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) treatment 1 completed NCT00244881
A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202) treatment 2 completed NCT00003455
Antineoplaston Therapy in Treating Women With Advanced Breast Cancer treatment 2 withdrawn NCT00369655
VEGF Trap in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT00602043
F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer No drug interventions diagnostic 2 completed NCT01868503
Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer treatment 2 terminated NCT00821964
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer treatment 2 completed NCT01720602
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy treatment Not Available completed NCT01729884
Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer treatment 2 terminated NCT00025584
PS-341 in Treating Women With Metastatic Breast Cancer treatment 2 completed NCT03475979
Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation Testing No drug interventions Not Available Not Available unknown_status NCT00509587
Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer treatment 2 completed NCT01938833
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer treatment 1 / 2 terminated NCT01873833
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer treatment 2 terminated NCT01487954
Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy No drug interventions supportive_care 2 completed NCT01722851
Circulating miRNAs. No drug interventions Not Available Not Available completed NCT01222377
Endoscopic Breast Surgery in Treating Patients With Breast Cancer No drug interventions treatment Not Available terminated NCT01478477
Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole No drug interventions prevention Not Available completed NCT00030498
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction treatment 1 completed NCT01741597
Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung diagnostic 1 withdrawn NCT01351597
A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer treatment 2 unknown_status NCT00098397
FR901228 in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT01939483
A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases treatment Not Available withdrawn NCT00055861
Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer treatment 2 completed NCT00054028
Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer treatment 1 / 2 completed NCT00006228
Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT01217411
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer treatment 1 terminated NCT01355393
Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer treatment 1 / 2 completed NCT01791478
BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer treatment 1 active_not_recruiting NCT01953588
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery treatment 3 active_not_recruiting NCT00045188
Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT00096109
Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer treatment 2 terminated NCT01783756
Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis treatment 1 / 2 completed NCT01712815
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer No drug interventions diagnostic Not Available terminated NCT01706432
Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer No drug interventions Not Available Not Available completed NCT02203552
Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer prevention 2 unknown_status NCT02624700
2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer treatment 2 terminated NCT02269670
Phase II Study of Everolimus Beyond Progression treatment 2 terminated NCT01918306
GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer treatment 1 / 2 terminated NCT00258349
Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer treatment 1 / 2 completed NCT01151449
Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer treatment 2 terminated NCT01243541
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel No drug interventions supportive_care Not Available terminated NCT01483196
Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery No drug interventions diagnostic Not Available completed NCT03530696
T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer treatment 2 completed NCT03750396
Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer No drug interventions treatment 2 recruiting NCT01155258
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors treatment 1 completed NCT00228358
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine treatment 1 completed NCT00028535
Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors treatment 1 completed NCT00077363
Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer treatment 2 completed NCT00912639
A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer treatment 4 unknown_status NCT00577122
Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer treatment 2 completed NCT00618657
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting treatment 2 completed NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu treatment 1 completed NCT06570031
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer treatment 1 active_not_recruiting NCT00077376
Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer treatment 2 completed NCT00307229
Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1) No drug interventions treatment 1 completed NCT06329089
Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast Cancer No drug interventions Not Available Not Available recruiting NCT01705340
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery treatment 1 terminated NCT00182767
Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer treatment 1 / 2 completed NCT00425672
ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment treatment 1 / 2 completed NCT00039455
Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer treatment 1 terminated NCT00733408
Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer treatment 2 completed NCT01876238
Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals in Breast Cancer No drug interventions supportive_care Not Available completed